NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

In retrospect, it is hard to avoid the conclusion that Fauci, who proclaimed, "I represent science," purposefully lied and ...

Existing projects are also on hold because research institutions cannot be certain they will be continued, or if they absorb ...

NIH now has a list – reviewed by NPR – of 130 of these awards from one part of the NIH, the National Institute of Allergy and ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

As a result of the stop work order, Vaxart said it had been forced to lay off 10% of its workforce. The company entered the ...

How Infectious Disease Doctors Can Keep Up in a Rapidly Evolving Field As with most areas of medicine, advances in infectious diseases are accelerating at a rapid clip, and it’s understandable that as ...

Researchers evaluated the potential clinical impact and cost-effectiveness of administering long-acting, injectable ...

Appili Therapeutics (APLIF) announced that, the Company along with its partners, have submitted applications for four new federal funding ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 (“INTEGRA”) study at the 2025 ...

Harms of race-specific lung function calculations extend to asthma and treatment, particularly in Black children.